Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1998-8-31
|
pubmed:abstractText |
Prostate intraepithelial neoplasia (PIN) is a purported prostate cancer precursor lesion and a candidate biomarker for efficacy assessment in prostate cancer chemoprevention trials. Loss of expression of the pi-class glutathione S-transferase enzyme GSTP1, which is associated with the hypermethylation of deoxycytidine residues in the 5'-regulatory CG island region of the GSTP1 gene, is a near-universal finding in human prostate cancer. GSTP1 expression was assessed by immunohistochemistry in 60 high-grade PIN samples adjacent to and distant from prostate adenocarcinoma. Whereas abundant enzyme polypeptide expression was evident in all normal prostatic tissues, all samples of high-grade PIN and adenocarcinoma were completely devoid of GSTP1. DNA from 10 high-grade PIN lesions was analyzed for GSTP1 CG island methylation changes using a PCR technique targeting a polymorphic (ATAAA)n repeat sequence in the promoter region of the GSTP1 gene. Somatic GSTP1 CG island methylation changes were detected in DNA from 7 of the 10 PIN lesions. Allele discrimination was possible for 5 of the 10 DNA samples: 2 of the 5 samples exhibited DNA methylation changes at both alleles; whereas 3 samples displayed no DNA methylation changes at either allele. GSTP1 CG island methylation changes were present in each of the five homozygous samples. Hypermethylation of the 5'-regulatory region of the GSTP1 gene may serve as an important molecular genetic biomarker for both prostate cancer and PIN. The finding of frequent GSTP1 methylation changes in PIN and prostate cancer supports a role for PIN lesions as a prostate cancer precursor and may provide insight to the molecular pathogenesis of prostate cancer.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1055-9965
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
531-6
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9641498-Adenocarcinoma,
pubmed-meshheading:9641498-DNA Methylation,
pubmed-meshheading:9641498-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:9641498-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:9641498-Glutathione Transferase,
pubmed-meshheading:9641498-Humans,
pubmed-meshheading:9641498-Immunohistochemistry,
pubmed-meshheading:9641498-Male,
pubmed-meshheading:9641498-Polymerase Chain Reaction,
pubmed-meshheading:9641498-Prostatic Intraepithelial Neoplasia,
pubmed-meshheading:9641498-Prostatic Neoplasms,
pubmed-meshheading:9641498-Tumor Markers, Biological
|
pubmed:year |
1998
|
pubmed:articleTitle |
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
|
pubmed:affiliation |
Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-2101, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|